How to Value Unlisted Shares: 5 Methods Explained (2026 Investor Guide)

Reviewed by Kanishk Dev Bangia, NISM Series XV Certified Research Analyst

Last Updated: May 2026 | Reg. No: NISM-202300182946

There is a platform that shows Tata Capital unlisted at ₹1,150. Then there is a dealer offering ₹980. And your friend’s broker claims “fair value is ₹1,400”. Three different valuations for a single stock at one point in time without an exchange-based price benchmark. How do you determine what is fair? When dealing with stocks off the exchange, you don’t get the luxury of outsourcing that decision to a screen shot. Instead, you need to know how to properly value the stock, even if you do it only superficially.

In this course, we will go through each of the five stock valuation techniques Indian retail investors and stock analysts rely on in the unlisted market in 2026, including: book value, comparable companies, DCF, transaction precedent, and asset-based valuation. All five techniques have their own merits and weaknesses. We'll also look at a use case scenario for each of them.

TL;DR

Method 1 — Book Value (P/B Ratio)

Book value per share = (Total Assets – Total Liabilities) ÷ No. of Outstanding Shares

Worked Example:

Let’s assume Tata Capital has total assets of ₹2,40,000 cr, total liabilities of ₹2,00,000 cr, and 100 cr outstanding shares. Book value per share =

(2,40,000 − 2,00,000) ÷ 100 = ₹400. Assuming unlisted price is ₹1,150, P/B = 2.88x

Is 2.88x P/B reasonable? Benchmark against other listed NBFC peers. Bajaj Finance trades ~4.5x−5.5x P/B, Cholamandalam ~4.0x P/B, Shriram Finance ~2.5x P/B. Tata Capital’s 2.88x P/B lies comfortably between listed peers − a reasonable multiple.

Question: When does this valuation technique work well?

Businesses that are asset-heavy, where the balance sheet represents economic value. Examples − NBFCs, banks, real estate, manufacturing firms with tangible assets.

Question: When does this valuation technique fail?

Asset-light businesses (IT services, FMCG, technology companies). For instance, Tata Consultancy Services trades at 12x+ P/B, which ignores the fact that TCS’ value lies in its people & client relationships, not in the balance sheet. Applying P/B for an asset-light business grossly undervalues the enterprise.

The 2026 disclaimer for unlisted businesses:

Book value is calculated using the latest filed balance sheet and income statement data, which could be up to 12−18 months old for unlisted companies.

Method 2 — Comparable Company Multiples

The most widely used approach to valuing retail unlisted business. Select peers who are publicly listed within the same industry and calculate their valuations using their valuation multiples applied to the target firm.

Three valuation multiples: - P/E multiple – for profit-making and growing firms - EV/EBITDA multiple – for firms with debt or varied capital structures (easier cross-company comparison) - P/B multiple – for financials and asset-heavy firms

How to select peers: similar revenue size (within 0.5x-2x), same end-industry, similar growth rate, similar margins. The use of cherry-picked peers to support either high or

This method is most widely used because it is objective (comparable peers are listed, comparable multiples can be seen), and straightforward ("the Company is like listed Company XYZ and therefore it deserves the same multiple").

When does it fail? - Market sentiment affects the sector’s comparables (a comparable that might make sense in a bull market will not do so in a bear market). Unlisted shares trade at a 10%-25% illiquidity premium compared to their listed peers (you cannot sell instantly) – most retail investors ignore this. The growth prospects of the companies differ; paying 65x on the basis of Bata’s multiple would mean overvaluing the company.

How much discount? Discount by 15%-20%. For thinly traded unlisted stocks, apply even a higher discount, like 25%-+.

Method 3 — DCF (Discounted Cash Flow)

DCF forecasts the future free cash flows, then discounts it back to the present at an appropriate rate of return, and finally sums up the total to arrive at the intrinsic value.

The four components that matter: 1. Revenue growth - Explicit 5-year forecast + Terminal growth 2. Operating margin - Existing margin, forecast expansion/compression 3. Reinvestment rate - Capex/Working capital/Revenue 4. Discount Rate (WACC) - Cost of Equity + Cost of Debt

Example: Let us assume a company is generating ₹100 cr free cash flow in the current year, grows its FCF at 15% p.a. for the next five years, then growing at 5% terminal growth rate with WACC of 12%

Year 1: ₹115 cr, PV = ₹102.7 Year 2: ₹132 cr, PV = ₹105.4 Year 3: ₹152 cr, PV = ₹108.2

• Year 4: ₹175 cr, PV = ₹111.1

• Year 5: ₹201 cr, PV = ₹114.1

Terminal Value (Year 5 onwards) = ₹201 cr x (1.05) / (0.12 - 0.05) = ₹3,015 cr; PV = ₹1,711 cr

Total Enterprise Value ≈ ₹2,253 cr

Less Net Debt = ₹2,253 cr - ₹300 cr = ₹1,953 cr

Equity Value (Per Share Intrinsic Value) = ₹1,953 cr / 42.55 crore shares ≈ ₹45.83

DCF's power: It looks at the future, not today. A 30%-grower is inherently worth more than a 5%-grower.

DCF's dangers: - GIGO - a 1% change in WACC or terminal growth changes result by 15-30%. Different analysts will have their own version of DCF for the same business. - Less data is available for Indian unlisted firms than listed ones. Inputs here may be based on guesstimates. - DCF loves stories. Companies that aren't fully cash-flow positive yet cannot be DCFed.

DCF in 2026 retail practice: As a sanity check on multiples, not as a valuation methodology. If your DCF says ₹500 and your comparables say ₹450, you're okay. If DCF says ₹500 and comparables say ₹1,200, one of them is wrong — investigate.

Method 4 — Transaction Precedent / Recent Deal-Based

What did the most recent valuation based on an equity offering or secondary sale say about the valuation of the company? This is the purest number you could hope to extract from an unquoted business, since it represents an actual sale.

Sources of prior transactions:

- Press releases on funding rounds from the company (most reliable)

- Crunchbase, Tracxn, Inc42 databases

- Secondary platform quotes (UnlistedZone, Planify, Stockify) – These quotes include actual prices of transactions - News reports on large block transactions

The strengths: Actual money changed hands at this price. This is not theoretical valuation but actual market preference.

The limitations: - The terms of the financing round (liquidation preferences, anti-dilution) create an illusion of higher valuations because of the preferential treatment of preferred stock over common stock. The true valuation would be much lower. - Transaction dates may be stale (6-18 months old), reflecting changes in the company since then. - Sample selection bias: Companies with a successful round of financing are covered. Those that failed are not reported, creating an upward skew in data.

Retail Rule of 2026: The most recent funding round price is the FLOOR for any serious negotiation, not the ceiling. If someone offers an unlisted security at higher price than most recent round price but doesn't have any business justification for that valuation, then they you are simply paying for hope.

The blind spots are: - Preferred share terms on funding rounds (liquidation preference, antidilution etc.), which render "headline" price to be misleading – common shares are worth less - The transaction is stale – it could be between 6 to 18 months old; the company has developed meanwhile - Bias from selection; only deals with successful funding rounds are covered by press – failures go unseen - Sentiment-driven valuation on secondary platforms, which skews price perception in up side direction

Retail Rule of 2026: The most recent funding round price is the FLOOR for any serious negotiation, not the ceiling. If someone offers an unlisted security at higher price than most recent round price but doesn't have any business justification for that valuation, then they you are simply paying for hope.

Method 5 — Asset-Based / Net Asset Value (NAV)

NAV = Market value of all assets - all liabilities ÷ Number of shares outstanding. Usually applied to holding companies where assets are the investments in other listed companies, REITs and investment trusts.

Worked example. If the holding company has investments in 3 listed firms valued at ₹500 cr, ₹300 cr and ₹200 cr = ₹1,000 cr market value of gross assets. Minus ₹100 cr liabilities = ₹900 cr net asset value. Dividing by 10 cr number of shares outstanding NAV/share comes to ₹90.

“Holding company discount”: Holding companies almost ALWAYS trade BELOW their NAV by a margin of 20-50%. Why? (a) double taxation because of dividends flowing through, (b) the management may not unlock value properly, (c) no ability to control the operations. Thus, if the NAV is ₹90, the correct price should be ₹50 to ₹72.

Usefulness of the method: Holding companies (as in Tata Sons/Bajaj Holdings in the unlisted universe), REITs and investment trusts. The holdings have observable market prices. The whole valuation is formula based.

Useless for: Operating firms as their NAV would mean only their liquidation value.

How to Triangulate (The Actual Working Method)

There is no magic formula to give you “the answer”. You perform 2-3 valuation methods, get a range:

Hypothetical example of synthesizing values of an unlisted IT Services company: Book Value: ₹120 per share Comparable Multiples (35x P/E vs. peer median, less 20% illiquidity): ₹450 DCF with 15% growth rate and 12% WACC: ₹510 Quote on most recent secondary platform: ₹480

Fair range: ₹450-510; middle ground of this range: ₹480. Book Value is too conservative as this is an IT Services business, and it doesn’t have any assets; discard this number as “bottom anchor”. The other 3 methods are close together – so you feel confident about the range of ₹450-510.

If the price is above the upper bound of your triangulated range, it is a bit too high; go away and come another day. If the price is within your range, it is okay to proceed. But if the price is below your bottom range point, ask yourself why.

The Liquidity Discount Question

Any unlisted valuation will have a liquidity discount against the corresponding listed peer multiple.

Listed stock can be traded in a matter of seconds. For unlisted stocks, one needs to find a counter-party and complete the demat transaction, which could take several weeks.

Typical 2026 discount brackets:

- High-volume unlisted stock (NSE, Tata Capital, CSK, Hero FinCorp): 10-15% discount - Moderate volume stocks: 15-25% discount - Low volume stocks: 25-40% discount - Virtually no volume: 40%+ and beyond – here valuation is irrelevant, since you can’t get out

Frequently Asked Questions

Question: Which valuation method is most reliable for unlisted shares?

There is no one best way to do this – triangulation of two to three ways would be the most reasonable range of approaches. For most active companies, Comparable Multiples (main) + DCF (sanity check) + transaction history (money-in-the-bank check) is the preferred route.

Question: How can I select appropriate peers for multiple comparisons?

Criterion (1): match industry/sub-industry,

(2): size of revenues within 0.5x – 2x,

(3): growth within 10 percentage points,

(4): margins within 5 percentage points.

A smaller group of peers based on these parameters would result in a more accurate comparison.

Question: What is the appropriate illiquidity discount for an unlisted share in 2026?

Answer : The average discount is 15-25%, assuming that the share trades actively in the secondary market. Use 25-40% if the share is thinly traded in the secondary market. A discount below 10% implies that the unlisted stock is overvalued versus listed peers.

Question: How frequently should I value my unlisted shareholdings?

At least once every quarter, following the quarterly financial results. Monthly valuations are preferable when there is significant secondary market liquidity. DRHP filing, new fundraising rounds, and CEO changes require immediate valuation irrespective of frequency.

Question: Is it possible to value an unlisted pre-revenue company?

Yes, but it doesn't fit any of the conventional techniques directly. In case of pre-revenue startups, the valuation process would usually include (a) use of the price from the most recent funding round as the starting point, (b) revenue multiple approach on projected revenue after 2-3 years, heavily discounted for execution risk, (c) qualitative comparables with the companies of the same development stage. Triangulation becomes even more essential since no one technique works properly.

Question: Does the price on the platform represent the fair market value?

No, not always. The price on the platform represents the state of the demand/supply on that platform on that specific day and may differ from the fair market value by 10-20% depending on many different factors.

Question: What will be my approach to valuing an unlisted company which has applied for DRHP, but hasn’t yet gone public?

The DRHP provides comprehensive information about the financials, comparisons with other companies, and the logic behind the valuation by the management itself. Take the estimated share price after listing from the DRHP (based on the issue price range), take the latest funding round figures as the second benchmark, and finally the multiples based on the disclosed financials.

Question: What is the difference between enterprise value and equity value?

Enterprise value (EV) = Market capitalization + Debt – Cash. It is the value of the entire organization, debt plus equity combined. Equity value is the value received by an equity shareholder, which is the residual after

debt is paid. For most retail purposes, equity value per share is what matters. EV/EBITDA is used for cross-company comparison because it neutralizes capital structure differences.

Disclaimers:

The above content is meant purely for educational and informational purposes. No part of it should be construed as an offer to invest in, or a recommendation or solicitation to buy or sell any security. All data presented here has been obtained from publicly available sources.